Bivalirudin monitored with the ecarin clotting time for anticoagulation during cardiopulmonary bypass

Anesth Analg. 2003 Feb;96(2):383-6, table of contents. doi: 10.1097/00000539-200302000-00015.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anesthesia, Intravenous
  • Anticoagulants / analysis*
  • Anticoagulants / pharmacology
  • Blood Coagulation / drug effects*
  • Cardiopulmonary Bypass*
  • Endopeptidases*
  • Female
  • Fibrinolytic Agents*
  • Hirudins / analogs & derivatives*
  • Hirudins / analysis*
  • Hirudins / pharmacology
  • Humans
  • In Vitro Techniques
  • Monitoring, Intraoperative / methods
  • Myocardial Infarction / surgery
  • Peptide Fragments / analysis*
  • Peptide Fragments / pharmacology
  • Recombinant Proteins / analysis*
  • Recombinant Proteins / pharmacology
  • Snake Venoms*
  • Time Factors

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Hirudins
  • Peptide Fragments
  • Recombinant Proteins
  • Snake Venoms
  • Endopeptidases
  • ecarin
  • bivalirudin